AlfreyA.C., Le GendreG.R., KaehnyW.D.: The dialysis enzephalopathy syndrome.New Engl. J. Med., 294, 184–188, 1976.
4.
WawschinekO., PetekW., LangJ., PogglitschH., HolzerH.: The determination of aluminium in human plasma.Mikrochim. Acta., 1, 335–339, 1982.
5.
PogglitschH., WawschinekO., HolzerH., PetekW., LadurnerG., KatschnigH., KorthalsCh.: The natural history of dialysis encephalopathy.Acta med. Austriaca, 7, 71–76, 1980.
6.
OndreickaR., GinterE., KortusJ.: Chronic toxicity of aluminium in rats and mice and its effects on phosphorus metabolism.Brit. J. Industr. Med., 23, 305–312, 1966.
7.
BerlyneG.M., YagilR., Ben AriJ., WeinbergerG., KnoffE., DanovitchG.M.: Aluminium toxicity in rats.LancetI, 564–568, 1972.
8.
KlatzoJ., WiśniewskiH., StreicherE.: Experimental production of neurofibrillary degeneration.Neuropath. exper. Neurol., 24, 1965, 1871–210.
9.
KopeloffL.M., BarreraE., KopeloffN.: Recurrent convulsive seizures in animals produced by immunologic and chemical means.Am. J. Psychiatry, 98, 881–902, 1942.
10.
DuneaG., MahurkarS.D., MamdaniB., SmithE.C.: Role of aluminium in dialysis dementia.Ann. Intern. Med., 88, 502–504, 1978.
11.
PlattsM.M., GoodeG.C., HislopJ.S.: Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis.Brit. Med. J., 2, 675–660, 1977.
BoyceB.F., EiderH.Y., FellS.G., NicholsonW.A., SmithG.D., DempsterD.W., GrayC.C., BoyleI.T.: Quantitation and localisation of aluminium in human cancellous bone in renal osteodystrophy.Scan. Electron Microsc.321–337, 1981.
20.
AckrillP., RalstonA.J., DayJ.P., HodgeK.C.: Successful removal of aluminium from patient with dialysis encephalopathy.LancetI, 692–693, 1980.
21.
PogglitschH., PetekW., WawschinekO., HolzerH.: Treatment of early stages of dialysis encephalopathy by aluminium depletion.LancetII, 1344–1345, 1981.
22.
Cournot-WitmerG., ZingraffJ., PlachotJ.J., EscaigF., LefèvreR., BoumatiP., BourdeauA., GarabédianM., GalleP., BourdeauR., DrückeT., BalsanS.: Aluminum localization in bone from hemodialyzed patients: Relationship to matrix mineralization.Kidney Intern., 20, 375–385, 1981.
23.
MayorG.H., SpragueJ.M., HouraniM.R., SanchezT.V.: Parathyroid hormone mediated aluminum deposition and egress in the rat.Kidney Intern., 17, 40–44, 1980.
24.
ClarksonE.M., LuckV.A., HynsonV.W., BaileyR.R., EastwoodJ.B., WoodheadJ.S., ClementsV.R., O'RiordanJ.L.H., DeWardenerH.E.: The effect of aluminium hydroxyde on calcium, phosphorus and aluminium balances, the serum parathyroid hormone concentration and the aluminium content of bone in patients with chronic renal failure.Clin. Sci., 43, 519–531, 1972.
25.
KnoppCh.: Untersuchungen mit Antacida: Über die phosphatbindenden Eigenschaften von Aluminiumhydroxyd.Sci. Pharm. (in press).
